NCT01265433 · OUTCOME
Immune Response
Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy · Source last updated 2024-10-09
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 12 weeks
What was measured
Immunogenicity of galinpepimut-S and control from a subset of participants
Analysis population: Data were available from 22 participants only
Groups in this outcome
Galinpepimut-S
Galinpepimut-S + Montanide + GM-CSF
Control
Montanide + GM-CSF
Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.
Analysis denominator · Participants
| Group | Source count |
|---|
| Galinpepimut-S | 10 |
|---|
| Control | 12 |
|---|
Reported measurements
CD4 Elispot
Positive
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Galinpepimut-S | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Control | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
Negative
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Galinpepimut-S | 4 | Not reported | Not reported | Not reported | Not reported |
|---|
| Control | 8 | Not reported | Not reported | Not reported | Not reported |
|---|
Not tested
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Galinpepimut-S | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
| Control | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
CD8 Elispot
Positive
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Galinpepimut-S | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Control | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
Negative
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Galinpepimut-S | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Control | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
Not tested
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Galinpepimut-S | 8 | Not reported | Not reported | Not reported | Not reported |
|---|
| Control | 8 | Not reported | Not reported | Not reported | Not reported |
|---|
Tetramer assay positive
Positive
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Galinpepimut-S | 1 | Not reported | Not reported | Not reported | Not reported |
|---|
| Control | 2 | Not reported | Not reported | Not reported | Not reported |
|---|
Negative
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Galinpepimut-S | 0 | Not reported | Not reported | Not reported | Not reported |
|---|
| Control | 3 | Not reported | Not reported | Not reported | Not reported |
|---|
Not tested
Values in Participants · Interval/dispersion: Not reported| Group | Value | Spread | Lower | Upper | Comment |
|---|
| Galinpepimut-S | 9 | Not reported | Not reported | Not reported | Not reported |
|---|
| Control | 7 | Not reported | Not reported | Not reported | Not reported |
|---|
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 1
- title
- Positive
- measurements
- group Id
- OG000
- value
- 4
- group Id
- OG001
- value
- 8
- title
- Negative
- measurements
- group Id
- OG000
- value
- 2
- group Id
- OG001
- value
- 3
- title
- Not tested
- title
- CD4 Elispot
- categories
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 1
- title
- Positive
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 3
- title
- Negative
- measurements
- group Id
- OG000
- value
- 8
- group Id
- OG001
- value
- 8
- title
- Not tested
- title
- CD8 Elispot
- categories
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 2
- title
- Positive
- measurements
- group Id
- OG000
- value
- 0
- group Id
- OG001
- value
- 3
- title
- Negative
- measurements
- group Id
- OG000
- value
- 9
- group Id
- OG001
- value
- 7
- title
- Not tested
- title
- Tetramer assay positive
- denoms
- counts
- group Id
- OG000
- value
- 10
- group Id
- OG001
- value
- 12
- units
- Participants
- description
- Immunogenicity of galinpepimut-S and control from a subset of participants
- groups
- description
- Galinpepimut-S + Montanide + GM-CSF
- id
- OG000
- title
- Galinpepimut-S
- description
- Montanide + GM-CSF
- id
- OG001
- title
- Control
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Data were available from 22 participants only
- reporting Status
- POSTED
- time Frame
- 12 weeks
- title
- Immune Response
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle